Antoine Daniel James, Williams Dominic P, Kipar Anja, Laverty Hugh, Park B Kevin
Medical Research Council Centre for Drug Safety Science, Liverpool, UK.
Department of Pharmacology and Therapeutics, Institute for Translational Medicine, Liverpool, UK.
Mol Med. 2020 Jan 30;26(1):13. doi: 10.1186/s10020-020-0140-z.
The Editors-in-Chief would like to alert readers that this article [1] is part of an investigation being conducted by the journal following the conclusions of an institutional enquiry at the University of Liverpool with respect to the quantitative mass spectrometry-generated results regarding acetylated and redox-modified HMGB1.
主编们特此提醒读者,本文[1]是该期刊在利物浦大学就定量质谱法生成的乙酰化和氧化还原修饰的高迁移率族蛋白B1(HMGB1)相关结果进行机构调查后所开展的一项调查的一部分。